# Emergent BioSolutions Inc. (EBS) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $743M |
| 2024 | $1.04B |
| 2023 | $1.05B |
| 2022 | $1.12B |
| 2021 | $1.77B |
| 2020 | $1.56B |
| 2019 | $1.11B |
| 2018 | $782M |
| 2017 | $561M |
| 2016 | $489M |
| 2015 | $523M |
| 2014 | $450M |
| 2013 | $313M |
| 2012 | $282M |
| 2011 | $273M |
| 2010 | $286M |
| 2009 | $235M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $156M |
| 2025-09-30 | $231M |
| 2025-06-30 | $141M |
| 2025-03-31 | $222M |
| 2024-09-30 | $294M |
| 2024-06-30 | $255M |
| 2024-03-31 | $300M |
| 2023-09-30 | $271M |
| 2023-06-30 | $338M |
| 2023-03-31 | $164M |
| 2022-09-30 | $240M |
| 2022-06-30 | $243M |
| 2022-03-31 | $305M |
| 2021-09-30 | $329M |
| 2021-06-30 | $398M |
| 2021-03-31 | $343M |
| 2020-09-30 | $385M |
| 2020-06-30 | $395M |
| 2020-03-31 | $193M |
| 2019-09-30 | $312M |
| 2019-06-30 | $243M |
| 2019-03-31 | $191M |
| 2018-09-30 | $174M |
| 2018-06-30 | $220M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/EBS/revenue)